UBS Maintains Neutral on Paychex, Raises Price Target to $142
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Mcveigh maintains a Neutral rating on Paychex (NASDAQ:PAYX) but raises the price target from $125 to $142.
October 02, 2024 | 2:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Kevin Mcveigh has maintained a Neutral rating on Paychex but increased the price target from $125 to $142, indicating a positive outlook on the stock's potential.
The increase in the price target from $125 to $142 suggests that UBS sees potential for Paychex's stock to appreciate, which is a positive signal for investors. However, the Neutral rating indicates that the analyst does not see a strong buy opportunity, balancing the positive price target adjustment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100